Search

And now for another smash hit…

CERN is getting ready to switch on its massive underground collider again. The Higgs boson, the standout discovery of the last few years, is in the bag, so what are physicists looking for now?

Cambridge: First of new generation of cancer drugs granted European approval

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

ETH Zürich: Fertile ground for innovative spirit

A total of 22 new companies were founded in 2014 by researchers from ETH Zurich. These spin-offs are among the most successful in Switzerland. One of the year's highlights was Covagen, which was acquired for over CHF 200 million. The latest figures also reveal that the university is on the right track with its promotion programmes.

Germany vows to speed a digital revolution

To stay competitive in the global race to develop advanced manufacturing technologies, German industry must define and develop the digital framework for the “Internet of Things,” enabling everything from driverless cars to smart cities and e-health, a top official tells Science|Business